CAS Medical Systems, Inc.

CAS Medical Systems, Inc. develops innovative medical devices focused on patient monitoring and neurological assessment, providing critical solutions in healthcare settings to enhance patient safety and care. CAS Medical Systems, Inc. specializes in medical devices that improve patient monitoring capabilities.

The company was founded in Branford, US, and has received a total funding of USD 15. 00 mn in Series A funding from Thomas, McNerney & Partners, with the most recent deal taking place on June 9, 2011. The company has been operational since its inception, focusing on developing advanced medical technologies to meet healthcare needs. CAS Medical Systems offers a range of medical devices, particularly in the realm of patient monitoring.

Their products are designed to improve the accuracy of neurological assessments and include advanced monitoring systems that serve hospitals and healthcare providers. The company caters to diverse geographical markets, ensuring their solutions address various clinical challenges while enhancing patient outcomes. In the most recent fiscal year of 2018, CAS Medical Systems reported a revenue of USD 21. 92 mn with an EBITDA loss of USD 2.

93 mn, highlighting the financial performance of their medical device solutions in the market. CAS Medical Systems plans to utilize the recent funding of USD 15 mn raised in June 2011 to enhance its product offerings and expand into new healthcare markets. The company aims to introduce upcoming innovations in patient monitoring technology that are expected to launch in the next fiscal year. Furthermore, they are targeting expansions into emerging markets in Asia-Pacific and Europe, intending to establish a presence by 2023.